Osteoblast precursor cell activity on HA surfaces of different treatments.
The clinical success of dental implants is governed by implant surfaces and bone cell responses that promote rapid osseointegration and long-term stability. The specific objective of this study was to investigate osteoblast precursor cell responses to hydroxyapatite (HA) surfaces of different treatments. Since the nature of bone cell responses in vitro is influenced by the properties of HA ceramics, this study was divided into two components: a chemical and crystallographic characterization of the HA ceramics and an in vitro cell culture study. The sintered HA samples were observed to have the highest crystallite size as compared to the as-received HA and calcined HA samples. No differences in the surface roughness and chemical composition were observed among the sintered, calcined, and as-received HA surfaces. In concurrence with the X-ray diffraction, high resolution XPS resolution of Ca 2p also indicated a higher crystallinity on sintered HA samples as compared to the calcined and as-received HA samples. As indicated by increased alkaline phosphatase-specific activity, increased cell-surface and matrix-associated protein, and 1.25 (OH2) vitamin D3-stimulated osteocalcin production, a more differentiated osteoblast-like phenotype was observed on the sintered HA surfaces compared to the as-received HA and calcined HA surfaces. An increased osteoblast-like cell activity on the sintered HA surfaces suggested that the crystallite size of HA surfaces may play an important role in governing cellular response.
Ong
J L
JL
University of Texas, Health Science Center at San Antonio, Department of Restorative Dentistry, San Antonio 78284-7890, USA.
Hoppe
C A
CA
Cardenas
H L
HL
Cavin
R
R
Carnes
D L
DL
Sogal
A
A
Raikar
G N
GN
D000469:Alkaline Phosphatase / Q000378:metabolism; D001672:Biocompatible Materials; D002117:Calcitriol / Q000494:pharmacology; D002460:Cell Line; D017886:Durapatite; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism; D008855:Microscopy, Electron, Scanning; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D015675:Osteocalcin / Q000096:biosynthesis; D013052:Spectrometry, X-Ray Emission; D013234:Stem Cells / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D013379:Substrate Specificity; D013499:Surface Properties; D014961:X-Ray Diffraction
D001672:Biocompatible Materials; D016326:Extracellular Matrix Proteins; D008565:Membrane Proteins; D015675:Osteocalcin; D017886:Durapatite; D000469:Alkaline Phosphatase; D002117:Calcitriol